Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Yvoir

Yvoir, BelgiumNot linked to an institution yet

3running trials
1closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

Active, not recruiting
A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLL
NCT02970318· Phase 3· Source
Active, not recruiting
Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL)
NCT02477696· Phase 3· Source
Active, not recruiting
An Open-label, Phase 2 Study of ACP-196 (Acalabrutinib) in Subjects With Mantle Cell Lymphoma
NCT02213926· Phase 2· Source

Researchers

No researcher is linked here yet.

Closed trials

Completed
A Study for Observing Severe Asthma in Patients Treated With Tezepelumab
NCT05677139· Source

Site data: ClinicalTrials.govUpdated 5 Nov 2026

Report an error